M&A: Page 4

  • Image attribution tooltip
    Adobe Stock

    Haemonetics inks $510M Cardiva takeover to expand hospital business

    The blood products medtech contends the deal will strengthen its portfolio in interventional cardiology and electrophysiology markets.

    By Jan. 21, 2021
  • Image attribution tooltip
    Adobe Stock

    Hillrom makes cardiac monitoring play with $375M BardyDx buy

    The deal fits Hillrom's existing heart portfolio and efforts to connect devices to the internet, analysts said, but one raised concerns about Medicare reimbursement.

    By Jan. 20, 2021
  • Thermo Fisher buys Mesa Biotech for $450M to bolster rapid point-of-care testing

    The all-cash acquisition, which includes the potential for an additional $100 million upon completion of milestones, adds Mesa's PCR test platform for SARS-CoV-2, influenza A and B, RSV and strep A to Thermo's portfolio.

    By Jan. 19, 2021
  • Philips to acquire Capsule Technologies in $635M deal, growing patient data capabilities

    The move follows the medtech giant's $2.8 billion acquisition of cardiac monitoring company BioTelemetry in December, one of 2020's largest deals.

    By Jan. 19, 2021
  • Image attribution tooltip
    Yujin Kim/MedTech Dive

    Pandemic propels health systems to mull insurer acquisitions, partnerships: JPM21

    Advocate Aurora CEO Jim Skogsbergh said "partnering for health plan capability is going to be critical to our success."

    By Samantha Liss • Jan. 14, 2021
  • Steris inks $4.6B buy of Cantel Medical amid flurry of M&A

    It's the biggest deal so far this year. Wall Street analysts said COVID-19 infection concerns should boost Cantel in the long term.

    By Jan. 13, 2021
  • Image attribution tooltip
    Adobe Stock

    Healthcare CFOs see fresh wave of M&A in 2021: BDO poll

    Financial distress, a desire to expand into new service lines and efforts to close infrastructure gaps are expected to fuel the upturn, according to the consultants.

    By Jan. 12, 2021
  • Image attribution tooltip

    Medtech M&A to take off after pandemic slowed deals in 2020: EY

    Dealmaking in 2021 will be fueled by financial firepower across the industry at an "all-time high" of nearly $500 billion, according to the consultants.

    By Jan. 10, 2021
  • PerkinElmer inks $591M Oxford Immunotec buy to challenge Qiagen in TB market

    The deal comes amid a flurry of medtech M&A during the first week of 2021. Hologic inked two acquisitions in the women's health space and Stryker said it would buy sensor maker OrthoSensor.

    By Jan. 8, 2021
  • Hologic's $230M Biotheranostics buy its 2nd M&A deal of 2021

    Some Wall Street analysts were surprised by the target, but others suggested the move could strengthen the company for a post-coronavirus environment.

    By Jan. 6, 2021
  • Image attribution tooltip
    Photo courtesy of Stryker

    Stryker buys sensor maker in bet on wearables in orthopaedics

    OrthoSensor's technology could complement the medtech's robotics platform and boost its data analytics capabilities, SVB Leerink analysts said in a Tuesday note on the acquisition.

    By Jan. 5, 2021
  • Hologic eyes future post COVID-19 with Somatex Medical tuck-in

    The medical device maker is bulking up its women's health business as molecular diagnostics sales surge due to the pandemic. Wall Street analysts have said these lines are equipped to withstand market uncertainties.

    By Jan. 5, 2021
  • Image attribution tooltip
    Adobe Stock

    The top medtech deals of 2020 (and one that got away)

    M&A activity bounced back in the second half of the year, with deals ranging from Teladoc's $18.5 billion Livongo buy to Stryker's drawn-out $4 billion acquisition of Wright Medical.

    By Jan. 4, 2021
  • Image attribution tooltip
    Getty / edited by Healthcare Dive

    Hospital giant Tenet goes big on ASCs

    A shift in focus to outpatient settings is also occurring among medical device companies. Both Stryker and Zimmer Biomet have made ASCs more of a priority over the last several years.

    By Samantha Liss • Dec. 22, 2020
  • Philips buys cardiac monitoring company BioTelemetry in $2.8B deal

    The Dutch conglomerate said that the move will expand its remote patient monitoring business beyond the hospital space. Baird called the pact a surprise but the valuation fair.

    By Dec. 18, 2020
  • Olympus to pay $300M to buy Veran for lung navigation system

    The deal is for $300 million up front, with another $40 million tied to an undisclosed milestone.

    By Dec. 7, 2020
  • Image attribution tooltip
    Courtesy of LivaNova/Businesswire

    LivaNova offloads heart valve tech to Gyrus Capital following investor pressure

    The announcement comes shortly after activist shareholder PrimeStone Capital demanded LivaNova sell or close the "likely loss-making" business line.

    By Maria Rachal • Dec. 3, 2020
  • Image attribution tooltip
    Adobe Stock

    Zimmer puts up $250M in surgical device deal, Boston Scientific nets $800M in BTG pharma sell-off

    The pandemic hasn't stopped M&A in the medtech industry, with Zimmer Biomet adding to its sternal closure device lineup via A&E Medical and Boston Scientific streamlining business with a sale to specialty pharma group SERB.

    By Dec. 1, 2020
  • Healthcare deals in Q4 predicted to fall from record-setting Q3: report

    Market research firm CB Insights believes the drop will carry over into the digital health sector too, an area that's seen historic investor interest in 2020 amid the coronavirus pandemic.

    By Rebecca Pifer • Nov. 25, 2020
  • Image attribution tooltip
    Getty Images

    Zimmer reports record robot installs, ASC-inspired M&A

    While the company benefited from a rebound in elective procedures, execs warned investors the recovery slowed as the third quarter drew to a close.

    By Nov. 6, 2020
  • Image attribution tooltip
    Adobe Stock

    Stryker closes Wright Medical acquisition after year-long wait

    The Kalamazoo, Michigan-based medtech highlighted the shoulder, elbow, wrist, hand, foot and ankle devices it's gained, along with preoperative planning technology, now that the deal is final.

    By Maria Rachal • Updated Nov. 11, 2020
  • Illumina defends Grail valuation amid much cheaper Exact-Thrive deal

    The biotech defended its $8 billion purchase price against Exact Sciences' $2.15 billion cancer screening takeout agreement announced this week, arguing Grail has more data and is likely to be first to market.

    By Oct. 30, 2020
  • Image attribution tooltip
    Permission granted by Medtronic/Beth Richman

    Medtronic acquires thyroid surgery tech in 7th tuck-in deal of 2020

    An addition to the medtech's pandemic-battered ENT business, Ai Biomed's PTeye system won De Novo authorization from FDA in 2018 for its ability to help surgeons spare important calcium-regulating tissue during procedures.

    By Maria Rachal • Oct. 29, 2020
  • Teleflex lines up $525M to buy hemostat specialist Z-Medica

    The medtech predicts the trauma surgery and emergency medicine-focused products will begin adding up to $70 million in revenue next year, providing growth drivers outside its key interventional urology segment.

    By Maria Rachal • Oct. 29, 2020
  • Smith & Nephew lays path to 10% growth for acquired Integra assets

    The medtech is moving deeper into the extremity orthopaedics turf fought over by the likes of Zimmer Biomet and Stryker acquisition target Wright Medical.

    By Oct. 29, 2020